Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Freeman

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selectionRichard B Freeman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2002
Diagnosing hepatocellular carcinoma: a virtual realityRichard B Freeman
Transplant International : Official Journal of the European Society for Organ Transplantation|February 19, 2013
Deceased donor risk factors influencing liver transplant outcomeRichard B Freeman
Transplantation|January 1, 2008
"Transplant tourism" in the United States?Richard B Freeman
The American Journal of Gastroenterology|January 11, 2008
Liver transplantation for hepatocellular carcinoma: racial disparities?Richard B Freeman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2002
In pursuit of the ideal liver allocation modelRichard B Freeman
Hepatology (Baltimore, Md.)|September 24, 2004
MELD and liver allocation: continuous quality improvementRichard B Freeman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2005
MELD and the quality of lifeRichard B Freeman
Expert Opinion on Pharmacotherapy|August 28, 2004
Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised hostRichard B Freeman
Journal of Hepatology|January 5, 2005
MELD: the holy grail of organ allocation?Richard B Freeman
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selectionRichard B Freeman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2002
Diagnosing hepatocellular carcinoma: a virtual realityRichard B Freeman
Transplant International : Official Journal of the European Society for Organ Transplantation|February 19, 2013
Deceased donor risk factors influencing liver transplant outcomeRichard B Freeman
Transplantation|January 1, 2008
"Transplant tourism" in the United States?Richard B Freeman
The American Journal of Gastroenterology|January 11, 2008
Liver transplantation for hepatocellular carcinoma: racial disparities?Richard B Freeman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2002
In pursuit of the ideal liver allocation modelRichard B Freeman
Hepatology (Baltimore, Md.)|September 24, 2004
MELD and liver allocation: continuous quality improvementRichard B Freeman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2005
MELD and the quality of lifeRichard B Freeman
Expert Opinion on Pharmacotherapy|August 28, 2004
Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised hostRichard B Freeman
Journal of Hepatology|January 5, 2005
MELD: the holy grail of organ allocation?Richard B Freeman
Pageof 8